News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Civitas Therapeutics to Present at JMP Securities Healthcare Conference


7/2/2013 9:35:12 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Civitas Therapeutics, Inc., a biopharmaceutical company with a lead program in Parkinson’s disease that leverages the ARCUS(TM) respiratory delivery platform, today announced that Glenn Batchelder, President and Chief Executive Officer, will present a corporate update at the JMP Securities Healthcare Conference in New York City on Tuesday, July 9, 2013 at 4:30 p.m. (EDT).

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES